SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-402021
Filing Date
2014-11-07
Accepted
2014-11-07 06:07:13
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d795263d10q.htm 10-Q 439456
2 EX-31.1 d795263dex311.htm EX-31.1 8810
3 EX-31.2 d795263dex312.htm EX-31.2 8809
4 EX-32.1 d795263dex321.htm EX-32.1 4783
  Complete submission text file 0001193125-14-402021.txt   3017703

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20140930.xml EX-101.INS 333717
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20140930.xsd EX-101.SCH 38311
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20140930_cal.xml EX-101.CAL 56462
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20140930_def.xml EX-101.DEF 92237
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20140930_lab.xml EX-101.LAB 285481
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20140930_pre.xml EX-101.PRE 186464
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 141202604
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences